exclusive-investments, e-invest* smart solution Fonds, PORTFOLIO, smart investments & investment strategie

Home

Investments

Portfolio

Nachrichten

Management

Nachrichten

Kontakt

Login

human tissue models for toxicology and drug discovery applications, precision medicine applications for induced pluripotent stems cells, translational genomics solutions, virtual reality 3-D visualization software, nano-structured absorbent materials

high-performance quantum computing systems, low-power, high-performance memory devices, novel industrial coatings, antibody drug conjugates for cancer therapy, inorganic nanowires and quantum dots for use in LED-backlit devices

bio- & nanotechnology content

Einen großer Anteil des strategisch angestrebten Nanotechnology content wird über die direkte Beteiligung am Risikokapitalspezialisten 180 Degree Capital Corp. (ehem. Harris & Harris Group, Inc.) realisiert. Über dieses langfristige Investment ist unser e-invest* smart solutions fonds indirekt an folgenden Unternehmen mit dem Schwerpunkt Bio- und Nanotechnologie beteiligt:

TheStreet, Lodo Therapeutics Corporation, Black Silicon Holdings, Phylagen, Enumeral Biomedical Holdings, Genome Profiling, Fleet Health Alliance



TOP HOLDINGS (INDIRECT)

Investment (indirekt*)

Details

Anteil**

D-Wave Systems, Inc.

high-performance quantum computing systems

  1,56%

AgBiome, LLC

research and discovery for agriculture and utilizing the crop microbiome

  1,43%

Adesto Technologies Corp.

low-power, high-performance memory devices

  1,27%

HZO, Inc.

coatings that protect electronics against damage from liquids

  1,o2%

HALE.life Corporation

developing a platform to facilitate precision health and medicine

  o,61%

Mersana Therapeutics, Inc.

developing antibody drug conjugates for cancer therapy

  o,61%

Nanosys, Inc.

inorganic nanowires and quantum dots for use in LED-backlit devices

  o,54%

TARA Biosystems, Inc.

human tissue models for toxicology and drug discovery applications

  o,54%

Essential Health Solutions, Inc.

software for information transfer amongst healthcare providers and consumers

  o,45%

Synacor, Inc.

multiplatform services and revenue partner for video, internet and communication

  o,4o%

Orig3n, Inc.

personalized medicine applications for induced pluripotent stems cells

  o,37%

Amgen, Inc.

rights to Milestone Payments from Acquisition of BioVex Group, Inc.

  o,35%

USA Truck, Inc.

providing over-the-road trucking and freight logistics

  o,34%

NGX Bio, Inc.

developing translational genomics solutions

  o,3o%

EchoPixel, Inc.

algorithms and software to improve visualization of data

  o,26%

Petra Pharma Corporation

small molecule inhibitors for treatment of cancer and metabolic diseases

  o,24%

ABSMaterials, Inc.

nano-structured absorbent materials for environmental remediation

  o,23%

Produced Water Absorbents, Inc.

nano-structured absorbent materials for environmental remediation of contaminated water

  o,2o%

Ensemble Therapeutics Corporation

DNA-Programmed Chemistry(TM) for the discovery of new classes of therapeutics

  o,12%

TheStreet, Inc.

financial news and proprietary data to consumers and businesses

  o,12%

Lodo Therapeutics Corporation

novel therapeutics derived from a metagenome-based Natural Product Discovery Platform

  o,1o%

Black Silicon Holdings, Inc.

interest in a company that develops silicon-based optoelectronic products

  o,o7%

Phylagen, Inc.

technology to improve human health and productivity

  o,o5%

Enumeral Biomedical Holdings, Inc.

therapeutics and diagnostics through functional assaying of single cells

  o,o4%

Genome Profiling, LLC

developing a platform to analyze and understand the epigenome

  o,o4%

Fleet Health Alliance, LLC

software for information transfer amongst healthcare providers and consumers

  o,o4%

Muses Labs, Inc.

developing a data analytics platform for precision medicine

  o,o4%

Accelerator IV-New York Corporation

identifying and managing emerging biotechnology companies

  o,o2%

Nano Terra, Inc.

surface chemistry and nano- manufacturing solutions

  o,o2%

Senova Systems, Inc.

next-generation sensors to measure pH

  o,o1%

OpGen, Inc.

tools for genomic sequence assembly and analysis

  o,o1%

SynGlyco, Inc.

synthetic carbohydrates for pharmaceutical applications

  o,oo%

Xenio Corp.

smart platform for LED lighting that enables local intelligence and communication

  o,oo%

Champions Oncology, Inc.

TumorGraft (TM) platform for personalized medicine and drug development

  o,oo%

AgTech Accelerator Corporation

identifying and managing emerging agriculture technologies companies

  o,oo%

Laser Light Engines, Inc.

solid-state light sources for digital cinema and large-venue projection displays

  o,oo%

Laird Technologies, Inc.

rights to Milestone Payments from Merger & Acquisition of Nextreme Thermal Solutions, Inc.

  o,oo%


*Investments indirekt über unsere Beteiligung an der 180 Degree Capital Corp.
**Anteil im e-invest* smart solutions fonds Portfolio



>>> letzte Aktualisierung, 22.o8.2o17 | Portfolio News / Transaktionen

Muses Labs, Accelerator IV-New York, Nano Terra, Senova Systems, OpGen, SynGlyco, Xenio Corp., Champions Oncology, AgTech Accelerator, Laser Light Engines, Laird Technologies

Die 180 Degree Capital Corp. (NASDAQ: TURN) mit Sitz in New York entwickelt seit Jahren erfolgreich ein erstklassiges Portfolio im Bio- und Nanotechnologiesektor. Wir nutzen diese Beteiligung als Investmentvehikel um u.a. auch in private, noch nicht börsengelistete Unternehmen wie z.B. die D-Wave Systems, Inc. (Quantencomputer) investieren zu können. Mehrere große Exits mit namhaften Unternehmen von Amgen bis Zeiss fundamentieren den exzellenten Track Record der 180 Degree Capital Corp..



D-Wave Systems, AgBiome, Adesto Technologies Corporation, HZO, HALE.life Corporation, Mersana Therapeutics, Nanosys, TARA Biosystems, Essential Health Solutions

e-invest*

Portfolio

Nachrichten

Kontakt

Links

Index

smart solution fonds

Transaktionen

Management

exclusive standard

Home

Nanotechnologie

Track Record

Kontakt

WestFach Leipzig

Investments

Risikomanagement

News

Impressum

Haas Elektrotechnik

Login

Wein als Investment

Sitemap

Börse Frankfurt

Datenschutz

Kunst als Investment

Handelsblatt



Synacor, Orig3n, Amgen, USA Truck, NGX Bio, EchoPixel, Petra Pharma Corporation, ABSMaterials, Produced Water Absorbents, Ensemble Therapeutics Corporation

©2o18 exclusive-investments*, Lanitz-Hassel-Tal | Impressum | Design by beatLesvirus .:. exclusive solutions*